Anacor Pharmaceuticals’ topical treatment for eczema came through with positive results in a pair of Phase III trials, propelling the biotech’s shares upward and setting the stage for an FDA application next year.

…read more

Source: Anacor soars as its eczema cream succeeds in Phase III


0 No comments